EV/EBITDA
84.23
+1.28+1.54%
Wed, 27 Nov 2024 14:30:00 GMT
Summary:
Pharming Group NV EV/EBITDA is currently 84.23, with a rise of +1.28 (+1.54%) during the most recent trading day. Over the past year, it has increased by +174.35 (+193.46%). PHAR EV/EBITDA is now -45.17% below its all-time high of 153.62.PHAR EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +1.5% |
| 1 m1 month | -11.4% |
| 3 m3 months | -38.1% |
| 6 m6 months | +5.3% |
| ytdytd | -34.4% |
| 1 y1 year | +193.5% |
| 5 y5 years | - |
PHAR EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 97.38 | -13.5% | 82.95 | +1.5% |
| 3 m | 3 months | 146.45 | -42.5% | 82.95 | +1.5% |
| 6 m | 6 months | 153.62 | -45.2% | 65.45 | +28.7% |
| 1 y | 1 year | 153.62 | -45.2% | -92.68 | +190.9% |
| 3 y | 3 years | 153.62 | -45.2% | -439.22 | +119.2% |
| 5 y | 5 years | 153.62 | -45.2% | -439.22 | +119.2% |
| alltime | all time | 153.62 | -45.2% | -439.22 | +119.2% |
Pharming Group NV EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | 84.23(-34.4%) |
| 2023 | 128.46(+530.3%) |
| Date | Value |
|---|---|
| 2022 | 20.38(+80.8%) |
| 2021 | 11.27(-29.1%) |
| 2020 | 15.89 |
FAQ
- What is Pharming Group NV EV/EBITDA?
- What is the all time high EV/EBITDA for Pharming Group NV?
- What is PHAR EV/EBITDA year-to-date change?
- What is Pharming Group NV EV/EBITDA year-on-year change?
What is Pharming Group NV EV/EBITDA?
The current EV/EBITDA of PHAR is 84.23
What is the all time high EV/EBITDA for Pharming Group NV?
Pharming Group NV all-time high EV/EBITDA is 153.62
What is PHAR EV/EBITDA year-to-date change?
Pharming Group NV EV/EBITDA has changed by -44.23 (-34.43%) since the beginning of the year
What is Pharming Group NV EV/EBITDA year-on-year change?
Over the past year, PHAR EV/EBITDA has changed by +174.35 (+193.46%)